Design Therapeutics Inc
NASDAQ:DSGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Design Therapeutics Inc
NASDAQ:DSGN
|
US |
|
M
|
Mattel Inc
XHAM:MTT
|
US |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
T
|
Truist Financial Corp
DUS:BBK
|
US |
|
R
|
RWE AG
DUS:RWE
|
DE |
|
I
|
Intuit Inc
DUS:ITU
|
US |
|
Annaly Capital Management Inc
NYSE:NLY
|
US |
|
NTT Inc
TSE:9432
|
JP |
|
Hypothekarbank Lenzburg AG
SIX:HBLN
|
CH |
|
M
|
Motorola Solutions Inc
F:MTLA
|
US |
|
TechnoPro Holdings Inc
F:30T
|
JP |
|
Action Construction Equipment Ltd
NSE:ACE
|
IN |
|
W
|
Wells Fargo & Co
DUS:NWT
|
US |
|
Ingen Technologies Inc
OTC:IGNT
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
PAR:ML
|
FR |
|
V
|
Vor Biopharma Inc
NASDAQ:VOR
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
F:MCHA
|
FR |
|
D
|
Duke Energy Corp
SWB:D2MN
|
US |
|
N
|
Northcoders Group PLC
F:5BN
|
UK |
|
Credit Agricole SA
XETRA:XCA
|
FR |
|
D
|
Danone SA
XHAM:BSN
|
FR |
|
T
|
Tejon Ranch Co
F:2TJ
|
US |
|
B
|
Brunswick Corp
XMUN:BWI
|
US |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
Bankruptcy Probability
Design Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Design Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Design Therapeutics Inc
NASDAQ:DSGN
|
605.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
38.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Design Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Design Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
